Trial Profile
Randomized Controlled Study to Evaluate the Efficacy and Safety of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2023
Price :
$35
*
At a glance
- Drugs Centella asiatica extract (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Acronyms MRCT Study
- Sponsors Oneness Biotech
- 06 Oct 2023 Results investigating the efficacy and safety of ON101, presented at the 59th Annual Meeting of the European Association for the Study of Diabetes
- 26 Jun 2023 Results of an analysis assessing efficacy and safety of ON101 using data from this MRCT study and In a real-world scenario (case collation from 133 patients) in Taiwan presented at the 83rd Annual Scientific Sessions of the American Diabetes Association
- 13 Jan 2023 According to a Oneness Biotech media release, results from this trial were published by the internationally renowned SCI journal JAMA Network OpenMeet.